Skip to main content

Exclusive news, data and analytics for financial market professionals

NegativeSPX4,136.481.04%Negative
NegativeIXIC12,006.951.59%Negative
NegativeDJI33,926.010.38%Negative
PositiveSTOXX460.770.34%Positive
PositiveFTSE7,901.801.04%Positive
PositiveN22527,509.460.39%Positive

Get real-time market data on Refinitiv

STSA.O

STSA.O

Official Data Partner

Latest Trade: trading lower--
Change; --; --

As of Feb 4 2023. Values delayed up to 15 minutes

Day Range: -- - --
52-Week Range: -- - --

About (STSA.O)

Company Information

Address

,

Contact Information

Industry

Latest News

BusinesscategorySatsuma Pharma's migraine drug fails late-stage study, shares crash
Satsuma Pharmaceuticals Inc said on Monday its experimental lead treatment for acute migraine headaches failed to meet the main goals of a late-stage trial, sending its shares down nearly 83% in premarket trade.
November 14, 2022

Markets Performance

Official Data Partner

Commodities

Future	Last	% Change
Gold	1,865.90	2.63%Negative
Copper	771.60	0.65%Negative
Brent Crude Oil	79.94	--
CBOT Soybeans	1,532.00	0.15%Negative

Currencies

Exchange	Last	% Change
--	--	--
--	--	--
JPY/USD	0.0076	--
CNY/USD	0.1476	--

Rates & Bonds

Name	Yield	Change
US 10Y	3.519	--
DE 10Y	2.214	+0.019
UK 10Y	3.046	-0.01
JP 10Y	0.486	--

Stocks

Index	Last	% Change
S&P 500	4,136.48	1.04%Negative
Euro STOXX 50	4,257.98	0.40%Positive
FTSE 100	7,901.80	1.04%Positive
Nikkei 225	27,509.46	0.39%Positive

Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes